Jack Collins
Director/Miembro de la Junta en T1D Exchange .
Perfil
Jack Collins is currently the Director at T1D Exchange since 2018.
Prior to this, he worked as the Chief Financial Officer at Fargo Ta LLC and as the Chief Operating & Financial Officer at PointCare Technologies, Inc. Mr. Collins holds an MBA from Babson College and an undergraduate degree from Suffolk University.
Cargos activos de Jack Collins
Empresas | Cargo | Inicio |
---|---|---|
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Director/Miembro de la Junta | 11/12/2018 |
Antiguos cargos conocidos de Jack Collins.
Empresas | Cargo | Fin |
---|---|---|
Fargo Ta LLC
Fargo Ta LLC Electronics/AppliancesConsumer Durables Fargo Ta LLC design and manufactures audio products. It offers table radios, bluetooth streaming, portable radios, special collections, internet radios, Hi-Fi systems, and clock radios. The company was founded by Thomas J. DeVesto on July 10, 2000 and is headquartered in Boston, MA. | Director Financiero/CFO | - |
PointCare Technologies, Inc.
PointCare Technologies, Inc. Pharmaceuticals: MajorHealth Technology PointCare Technologies, Inc. develops, manufactures and markets medical diagnostic products. It offers PointCare NOW, an analyzer and reagent system for diagnostic management of HIV/AIDS patients at the point-of-care, CD4NOW Reagent Kit 100, an analyzer and reagent system. The company was founded by Petra B. Krauledat and Peter W. Hansen in 2003 and is headquartered in Marlborough, MA. | Director Financiero/CFO | - |
Formación de Jack Collins.
Babson College | Masters Business Admin |
Suffolk University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Fargo Ta LLC
Fargo Ta LLC Electronics/AppliancesConsumer Durables Fargo Ta LLC design and manufactures audio products. It offers table radios, bluetooth streaming, portable radios, special collections, internet radios, Hi-Fi systems, and clock radios. The company was founded by Thomas J. DeVesto on July 10, 2000 and is headquartered in Boston, MA. | Consumer Durables |
PointCare Technologies, Inc.
PointCare Technologies, Inc. Pharmaceuticals: MajorHealth Technology PointCare Technologies, Inc. develops, manufactures and markets medical diagnostic products. It offers PointCare NOW, an analyzer and reagent system for diagnostic management of HIV/AIDS patients at the point-of-care, CD4NOW Reagent Kit 100, an analyzer and reagent system. The company was founded by Petra B. Krauledat and Peter W. Hansen in 2003 and is headquartered in Marlborough, MA. | Health Technology |
T1D Exchange
T1D Exchange Pharmaceuticals: MajorHealth Technology T1D Exchange is a nonprofit organization that was established in 2010 with initial and ongoing support from the Leona M. and Harry B. Helmsley Charitable Trust. T1D Exchange is based in Boston, MA. The non-profit company is dedicated to improving outcomes for the entire T1D population through real-world evidence and clinical data collection and analysis. T1D Exchange is a leading provider of real-world evidence, identifying gaps in data and redefining best practices to improve the lives of those living with T1D. The company actively supports quality improvement and innovation through its quality improvement collaborative, patient registry, and data-oriented research services. David Walton has been the CEO of the company since 2018. | Health Technology |
- Bolsa de valores
- Insiders
- Jack Collins